000623 Jilin Aodong Pharmaceutical Group
- 13.43
- -0.09-0.67%
Jilin Aodong Pharmaceutical Group News
Jilin Aodong Pharmaceutical Group: Announcement regarding the directors and general manager's shareholding in the company.
Jilin Aodong Pharmaceutical Group: Voluntary disclosure announcement regarding the holding subsidiary obtaining the listing verification certificate of traditional chinese medicine formula granules.
Jilin Aodong Pharmaceutical Group: Announcement of the release of pledge of shares by shareholders of Jilin Aodong Pharmaceutical Group Co., Ltd.
Jilin Aodong Pharmaceutical Group: Investor Relations Event Log for July 3, 2024
Jilin Aodong Pharmaceutical Group: Voluntary disclosure announcement regarding the holding subsidiary obtaining the listing verification certificate of traditional chinese medicine formula granules.
Jilin Aodong Pharmaceutical Group: Dividend announcement for the fiscal year 2023.
Jilin Aodong Pharmaceutical Group: Voluntary disclosure announcement regarding the holding subsidiary obtaining the listing verification certificate of traditional chinese medicine formula granules.
Jilin Aodong Pharmaceutical Group: May 29, 2024 Investor Relations Activity Schedule
Jilin Aodong Pharmaceutical Group: Voluntary Information Disclosure Notice on the Holding Subsidiary Obtaining a Registration Certificate for the Marketing of Chinese Medicine Formulated Granules
Jilin Aodong Pharmaceutical Group: 000623 Jilin Aodong Investor Relations Management Information 20240519
Jilin Aodong Pharmaceutical Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Jilin Aodong Pharmaceutical Group: Legal Opinion of Beijing Kyoto (Dalian) Law Firm on Jilin Aodong Pharmaceutical Group Co., Ltd. holding the 2023 Annual General Meeting of Shareholders
Jilin Aodong Pharmaceutical Group: Announcement on attending the online group results briefing
Jilin Aodong Pharmaceutical Group: May 14, 2024 Investor Relations Activity Schedule
Jilin Aodong Pharmaceutical Group: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Jilin Aodong Pharmaceutical Group: Voluntary Information Disclosure Notice Concerning the Holding Subsidiary Obtaining a Notice of Approval for Drug Supplementation Applications
Jilin Aodong Pharmaceutical Group: 2024 First Quarter Report
Jilin Aodong Pharmaceutical Group: Notice on changing the registered capital of the company, revising the “Articles of Association”, and completing the registration of industrial and commercial changes and issuing a business license
Jilin Aodong Pharmaceutical Group: Announcement on the issuance results of the first issue of 2024 medium-term notes (science and technology innovation notes)
Aodong, Jilin: Announcement on completion of cancellation of share repurchases and share changes
Analysis
Price Target
No Data
